OSEL Devices Ltd Publishes H1 FY27 Earnings Call Transcript
Key highlights
- OSEL Devices Ltd published the transcript of its H1 FY27 earnings call on November 20, 2026, following the November 16 call.
- Osel Devices reported H1 FY27 revenue of Rs 193.60 crore, up 31.8% year on year.
- H1 FY27 EBITDA was Rs 32.50 crore and profit after tax was Rs 18.10 crore, up 31.9% and 19.1%, respectively.
- Osel Devices expects its 10-year Bharat Mandapam LED concession to generate annual annuity revenue above Rs 15.00 crore.
powered by IRIS

OSEL Devices Ltd published the transcript of its H1 FY27 earnings call on November 20, 2026, documenting management’s discussion of Rs 193.60 crore in first-half revenue, a 31.8% year-on-year increase for the period ended September 30, 2026. The call, held on November 16, also covered developments across its LED display, hearing-health and mobile businesses.
Know OSEL Devices inside out
Results, valuation, peers and who's buying, in one view.
What did OSEL Devices Ltd file with the exchange?
OSEL Devices Ltd filed the transcript of its H1 FY27 earnings conference call, which was held on November 16, 2026. The document provides a record of management commentary and analyst questions following the company’s unaudited financial results for the half year ended September 30, 2026.
The filing is relevant because it sets out the operational points management discussed after the reported first-half results. Osel Devices said revenue from operations rose 31.8% year on year to Rs 193.60 crore. EBITDA increased 31.9% to Rs 32.50 crore, while profit after tax increased 19.1% to Rs 18.10 crore.
Management described LED display as the company’s largest vertical in the first half, contributing 40% of revenue. Hearing health contributed 31%, while mobile accounted for about 28%. These percentages are management’s stated revenue-mix figures from the call.
What did management say about Osel Devices’ operating progress?
Osel Devices said it was moving closer to end customers across its three business areas through clinics in hearing health, software and concessions in LED displays, and branded smartphones in mobile. The management commentary linked this approach to building recurring revenue streams and expanding customer-facing channels.
In LED displays, the company said its content-management-system software was running on more than 1,000 displays at over 300 locations. Management said this software activity generates recurring monthly revenue alongside the hardware business. Osel Devices also disclosed an original-equipment-manufacturer agreement with Colorlight for controllers and video processors that were previously imported and are now intended to be manufactured in India.
The company further referred to a 10-year public-private-partnership concession with India Trade Promotion Organisation after the half-year close. The agreement involves deployment of 15,000 square feet of LED displays at Bharat Mandapam. Management said it expects the project to generate annual annuity revenue of more than Rs 15.00 crore, with growth over time.
How are hearing health and mobile contributing to Osel Devices’ strategy?
Osel Devices said its hearing-health business accounted for 31% of H1 FY27 revenue and that it remains the largest supplier of hearing aids to the Government of India. Management highlighted its clinic-led approach through SFL Hearing Solutions, stating that sales through clinics can earn more than tender-led device sales.
Through its partnership with Petals Healthcare, the SFL network had expanded to 41 clinics and entered West Bengal, according to the call. Osel Devices also said its Greater Noida plant is registered with the US Food and Drug Administration and has received a ZED Gold certification. The company presented these developments as supporting its position in regulated export markets.
In mobile, management said the segment contributed about 28% of first-half revenue and was its fastest-growing business during the period. Osel Devices launched its first consumer smartphone, the Philips S7221 5G model, in September and said it was also launched on Amazon. The company stated that a facility is targeted to be commercialised from April 2027 as an export and OEM hub.
Got a follow-up? Ask IRIS
What does the transcript show about financial and execution matters?
The transcript records strong reported growth in revenue, EBITDA and profit, while also giving investors details on the operating initiatives management is pursuing. The Bharat Mandapam concession, software-led recurring revenue, clinic expansion and mobile launch were the main strategic developments discussed on the call.
The call also included investor questions on cash flow, receivables, borrowings and balance-sheet reconciliation. Commentary available from the call noted that operating cash flow was negative and receivables and borrowings had increased, while management deferred some reconciliation and cash-flow questions to a chief financial officer yet to join. The transcript does not disclose a revised FY27 revenue or EBITDA guidance figure; management said execution remained on track with earlier guidance.
For investors, the filing provides context beyond the first-half profit and revenue numbers. It identifies the company’s reliance on LED displays as the largest business, while showing management’s efforts to add recurring and direct-to-customer revenue sources in the other segments. The disclosed projects and partnerships remain subject to execution as described by management.
Why does the November 20 filing matter to investors?
The November 20 filing matters because an earnings-call transcript gives investors access to management’s explanation of reported results and its priorities after the financial period closes. In this case, Osel Devices used the call to discuss a 31.8% rise in H1 revenue, segment mix, the Bharat Mandapam concession and its consumer smartphone launch.
It also places the first-half numbers alongside issues raised during the analyst interaction. Revenue and EBITDA grew at broadly similar rates, but profit growth was lower than both measures. Meanwhile, the references to negative operating cash flow, higher receivables and higher borrowings make working-capital and funding information relevant areas for investors tracking subsequent disclosures.
Conclusion
OSEL Devices Ltd’s filing publishes the discussion surrounding H1 FY27 results, in which revenue reached Rs 193.60 crore, EBITDA was Rs 32.50 crore and profit after tax was Rs 18.10 crore. The transcript also records management’s focus on LED software and concessions, hearing-health clinics, and the newly launched consumer smartphone business.
Investors will next watch execution of the Bharat Mandapam concession, progress in the clinic network, the planned April 2027 commercialisation of the export and OEM hub, and subsequent disclosures on receivables, borrowings and operating cash flow. Management did not provide a revised FY27 revenue or EBITDA target in the call transcript.


